Allergy pill trial aims to halt silent liver damage
NCT ID NCT05616442
Summary
This study tested whether ketotifen, a common allergy and asthma medication, could help patients with non-alcoholic fatty liver disease (NAFLD). Researchers enrolled 60 adults with NAFLD to see if the drug could safely reduce liver scarring and inflammation. The goal was to see if this existing drug could offer a new way to manage this common, progressive liver condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Tanta Unuversity
Tanta, 34518, Egypt
Conditions
Explore the condition pages connected to this study.